These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22622016)

  • 1. In silico ligand based design of indolylpiperidinyl derivatives as novel histamine H(1) receptor antagonists.
    Paliwal S; Singh S; Pal M
    Drug Discov Ther; 2012 Apr; 6(2):69-77. PubMed ID: 22622016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools.
    Roy K; Mandal AS
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):205-23. PubMed ID: 18608745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of novel histamine H1 antagonists: indolylpiperidinyl benzoic acid derivatives.
    Fonquerna S; Miralpeix M; Pagès L; Puig C; Cardús A; Antón F; Cárdenas A; Vilella D; Aparici M; Calaf E; Prieto J; Gras J; Huerta JM; Warrellow G; Beleta J; Ryder H
    J Med Chem; 2004 Dec; 47(25):6326-37. PubMed ID: 15566302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A QSAR analysis of 2-phenoxy-N-substituted acetamide analogues as hypoxia-inducible factor-1(HIF-1) inhibitors: a rational approach to anticancer drug design.
    Noolvi MN; Patel HM; Kamboj S
    Med Chem; 2012 Jul; 8(4):599-614. PubMed ID: 22530909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Structure-Activity Relationship Study of Imidazole-5-Carboxylic Acid Derivatives as Angiotensin II Receptor Antagonists Combining 2D and 3D QSAR Methods.
    Sharma MC
    Interdiscip Sci; 2016 Mar; 8(1):1-10. PubMed ID: 26202941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR by LFER model of HIV protease inhibitor mannitol derivatives using FA-MLR, PCRA, and PLS techniques.
    Leonard JT; Roy K
    Bioorg Med Chem; 2006 Feb; 14(4):1039-46. PubMed ID: 16213730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring QSAR for substituted 2-sulfonyl-phenyl-indol derivatives as potent and selective COX-2 inhibitors using different chemometrics tools.
    Khoshneviszadeh M; Edraki N; Miri R; Hemmateenejad B
    Chem Biol Drug Des; 2008 Dec; 72(6):564-74. PubMed ID: 19090923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of novel quinazolinone derivatives as inhibitors for 5HT7 receptor.
    Chitta A; Jatavath MB; Fatima S; Manga V
    J Recept Signal Transduct Res; 2012 Feb; 32(1):3-16. PubMed ID: 22171569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative structure-activity relationships in a set of thiazolidin -4-ones acting as H1-histamine antagonists.
    Bolognese A; Diurno MV; Greco G; Grieco P; Mazzoni O; Novellino E; Perissutti E; Silipo C
    J Recept Signal Transduct Res; 1995; 15(1-4):631-41. PubMed ID: 8903969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-activity relationship (QSAR) study of a series of benzimidazole derivatives as inhibitors of Saccharomyces cerevisiae.
    Podunavac-Kuzmanović SO; Cvetković DD; Jevrić LR; Uzelac NJ
    Acta Chim Slov; 2013; 60(1):26-33. PubMed ID: 23841329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modelling studies for the discovery of new substituted pyridines derivatives with angiotensin II AT1 receptor antagonists.
    Sharma MC
    Interdiscip Sci; 2014 Sep; 6(3):197-207. PubMed ID: 25205497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring three-dimensional quantitative structural activity relationship (3D-QSAR) analysis of SCH 66336 (Sarasar) analogues of farnesyltransferase inhibitors.
    Equbal T; Silakari O; Ravikumar M
    Eur J Med Chem; 2008 Jan; 43(1):204-9. PubMed ID: 17442459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative QSAR modeling of CCR5 receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas.
    Thomas Leonard J; Roy K
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4467-74. PubMed ID: 16806923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring QSAR and QAAR for inhibitors of cytochrome P450 2A6 and 2A5 enzymes using GFA and G/PLS techniques.
    Roy K; Roy PP
    Eur J Med Chem; 2009 May; 44(5):1941-51. PubMed ID: 19110342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A steric approach for the design of antihistamines with low muscarinic receptor antagonism.
    Zhang MQ; Walczynski K; Timmerman H
    Inflamm Res; 1995 Apr; 44 Suppl 1():S90-1. PubMed ID: 8521019
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists.
    Dastmalchi S; Hamzeh-Mivehroud M; Ghafourian T; Hamzeiy H
    J Mol Graph Model; 2008 Jan; 26(5):834-44. PubMed ID: 17561422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the electronic and physicochemical parameters on the carcinogenesis activity of some sulfa drugs using QSAR analysis based on genetic-MLR and genetic-PLS.
    Deeb O; Hemmateenejad B; Jaber A; Garduno-Juarez R; Miri R
    Chemosphere; 2007 May; 67(11):2122-30. PubMed ID: 17307223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSAR studies on aminothiazole derivatives as aurora a kinase inhibitors.
    Qin J; Xi L; Du J; Liu H; Yao X
    Chem Biol Drug Des; 2010 Dec; 76(6):527-37. PubMed ID: 21040493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimycobacterial and H1-antihistaminic activity of 2-substituted piperidine derivatives.
    Weis R; Schweiger K; Faist J; Rajkovic E; Kungl AJ; Fabian WM; Schunack W; Seebacher W
    Bioorg Med Chem; 2008 Dec; 16(24):10326-31. PubMed ID: 18977145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.